☰

Evan M. Sloane, Ph.D. - Publications

Affiliations: 
Psychology University of Colorado, Boulder, Boulder, CO, United States 
Tree Info Grants Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Loram LC, Strand KA, Taylor FR, Sloane E, Van Dam AM, Rieger J, Maier SF, Watkins LR. Adenosine 2A receptor agonism: A single intrathecal administration attenuates motor paralysis in experimental autoimmune encephalopathy in rats. Brain, Behavior, and Immunity. 46: 50-4. PMID 25653191 DOI: 10.1016/J.Bbi.2015.01.014  0.54
2010 Ramos KM, Lewis MT, Morgan KN, Crysdale NY, Kroll JL, Taylor FR, Harrison JA, Sloane EM, Maier SF, Watkins LR. Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders. Neuroscience. 169: 1888-900. PMID 20547213 DOI: 10.1016/J.Neuroscience.2010.06.014  0.673
2010 Soderquist RG, Sloane EM, Loram LC, Harrison JA, Dengler EC, Johnson SM, Amer LD, Young CS, Lewis MT, Poole S, Frank MG, Watkins LR, Milligan ED, Mahoney MJ. Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration. Pharmaceutical Research. 27: 841-54. PMID 20224990 DOI: 10.1007/S11095-010-0077-Y  0.784
2009 Loram LC, Harrison JA, Sloane EM, Hutchinson MR, Sholar P, Taylor FR, Berkelhammer D, Coats BD, Poole S, Milligan ED, Maier SF, Rieger J, Watkins LR. Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 14015-25. PMID 19890011 DOI: 10.1523/Jneurosci.3447-09.2009  0.822
2009 Sloane E, Langer S, Jekich B, Mahoney J, Hughes T, Frank M, Seibert W, Huberty G, Coats B, Harrison J, Klinman D, Poole S, Maier S, Johnson K, Chavez R, et al. Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain. Gene Therapy. 16: 1210-22. PMID 19571887 DOI: 10.1038/Gt.2009.79  0.766
2009 Sloane EM, Soderquist RG, Maier SF, Mahoney MJ, Watkins LR, Milligan ED. Long-term control of neuropathic pain in a non-viral gene therapy paradigm. Gene Therapy. 16: 470-5. PMID 19262611 DOI: 10.1038/Gt.2009.21  0.823
2009 Soderquist RG, Milligan ED, Sloane EM, Harrison JA, Douvas KK, Potter JM, Hughes TS, Chavez RA, Johnson K, Watkins LR, Mahoney MJ. PEGylation of brain-derived neurotrophic factor for preserved biological activity and enhanced spinal cord distribution. Journal of Biomedical Materials Research. Part A. 91: 719-29. PMID 19048635 DOI: 10.1002/Jbm.A.32254  0.669
2009 Sloane E, Ledeboer A, Seibert W, Coats B, van Strien M, Maier SF, Johnson KW, Chavez R, Watkins LR, Leinwand L, Milligan ED, Van Dam AM. Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. Brain, Behavior, and Immunity. 23: 92-100. PMID 18835435 DOI: 10.1016/J.Bbi.2008.09.004  0.693
2009 Loram L, Sholar P, Taylor F, Harrison J, Hutchinson M, Maier S, Rieger J, Watkins L, Sloane E. Adenosine 2A receptor agonist produces long-duration reversal of neuropathic pain via sustained release of spinal interleukin-10 The Journal of Pain. 10: S39. DOI: 10.1016/J.Jpain.2009.01.165  0.725
2009 Loram L, Sloane E, Harrison J, Sholar P, Taylor F, Hutchinson M, Maier S, Rieger J, Watkins L. 80. Long-duration reversal of neuropathic pain via sustained release of spinal interleukin-10 is mediated by adenosine 2A receptor activation Brain, Behavior, and Immunity. 23: S47. DOI: 10.1016/J.Bbi.2009.06.085  0.735
2008 Milligan ED, Sloane EM, Watkins LR. Glia in pathological pain: a role for fractalkine. Journal of Neuroimmunology. 198: 113-20. PMID 18547654 DOI: 10.1016/J.Jneuroim.2008.04.011  0.803
2007 Ledeboer A, Jekich BM, Sloane EM, Mahoney JH, Langer SJ, Milligan ED, Martin D, Maier SF, Johnson KW, Leinwand LA, Chavez RA, Watkins LR. Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain, Behavior, and Immunity. 21: 686-98. PMID 17174526 DOI: 10.1016/J.Bbi.2006.10.012  0.8
2007 Watkins LR, Wieseler-Frank J, Hutchinson MR, Ledeboer A, Spataro L, Milligan ED, Sloane EM, Maier SF. Neuroimmune interactions and pain: The role of immune and glial cells Psychoneuroimmunology, Two-Volume Set. 1: 393-414. DOI: 10.1016/B978-012088576-3/50023-X  0.773
2006 Milligan ED, Soderquist RG, Malone SM, Mahoney JH, Hughes TS, Langer SJ, Sloane EM, Maier SF, Leinwand LA, Watkins LR, Mahoney MJ. Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. Neuron Glia Biology. 2: 293-308. PMID 18079973 DOI: 10.1017/S1740925X07000488  0.812
2006 Milligan ED, Sloane EM, Langer SJ, Hughes TS, Jekich BM, Frank MG, Mahoney JH, Levkoff LH, Maier SF, Cruz PE, Flotte TR, Johnson KW, Mahoney MM, Chavez RA, Leinwand LA, et al. Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain. 126: 294-308. PMID 16949747 DOI: 10.1016/J.Pain.2006.07.009  0.83
2006 Hughes T, Langer S, Sloane E, Mahoney J, Jekich B, Johnson K, Chavez R, Milligan E, Watkins L, Leinwand L. 260. ITRs Necessary for IL-10 Encoding Naked Plasmid Induced Reversal of Chronic Pain State in Rat Molecular Therapy. 13: S100. DOI: 10.1016/J.Ymthe.2006.08.287  0.834
2006 Milligan ED, Langer SJ, Hughes TS, Sloane EM, Mahoney JH, Jekich BM, Maier SF, Leinwand LA, Watkins LR. 259. Plasmid DNA Encoding the Anti-Inflammatory Cytokine Gene, Interleukin-10 (IL-10) for Chronic Pain Control: Taking Advantage of Nuclear Scaffold/Matrix Attachment Regions Molecular Therapy. 13: S99. DOI: 10.1016/J.Ymthe.2006.08.286  0.793
2006 Milligan E, Mahoney M, Soderquist R, Sloane E, Coats B, Mahoney J, Langer S, Leinwand L, Maier S, Chavez R, Watkins L. (624) The Journal of Pain. 7: S14. DOI: 10.1016/J.Jpain.2006.01.026  0.638
2006 Ledeboer A, Jekich BM, Sloane EM, Langer SJ, Milligan ED, Mahoney JH, Maier SF, Leinwand LA, Chavez RA, Watkins LR, Johnson KW. Novel approaches to control paclitaxel-induced neuropathic pain: Efficacy of interleukin-10 gene therapy and the blood–brain barrier permeable glial modulator, AV411 Brain, Behavior, and Immunity. 20: 43. DOI: 10.1016/J.Bbi.2006.04.082  0.77
2005 Milligan ED, Langer SJ, Sloane EM, He L, Wieseler-Frank J, O'Connor K, Martin D, Forsayeth JR, Maier SF, Johnson K, Chavez RA, Leinwand LA, Watkins LR. Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. The European Journal of Neuroscience. 21: 2136-48. PMID 15869510 DOI: 10.1111/J.1460-9568.2005.04057.X  0.798
2005 Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, Maier SF, Watkins LR. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain. 115: 71-83. PMID 15836971 DOI: 10.1016/J.Pain.2005.02.009  0.817
2005 Milligan ED, Sloane EM, Langer SJ, Cruz PE, Chacur M, Spataro L, Wieseler-Frank J, Hammack SE, Maier SF, Flotte TR, Forsayeth JR, Leinwand LA, Chavez R, Watkins LR. Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Molecular Pain. 1: 9. PMID 15813997 DOI: 10.1186/1744-8069-1-9  0.804
2005 Twining CM, Sloane EM, Schoeniger DK, Milligan ED, Martin D, Marsh H, Maier SF, Watkins LR. Activation of the spinal cord complement cascade might contribute to mechanical allodynia induced by three animal models of spinal sensitization. The Journal of Pain : Official Journal of the American Pain Society. 6: 174-83. PMID 15772911 DOI: 10.1016/J.Jpain.2004.11.011  0.762
2005 Milligan ED, Mahoney MJ, Langer SJ, Hughes T, Sloane EM, Mahoney J, Jekich B, Cruz PE, Flotte TR, Maier SF, Johnson KW, Leinwand LA, Chavez RA, Watkins LR. 644. Gene Delivery for Chronic Pain Control: Micrcroencapsulated Plasmid DNA Encoding the Anti-Inflammatory Cytokine Gene, Interleukin-10 (IL-10) Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.184  0.779
2004 Spataro LE, Sloane EM, Milligan ED, Wieseler-Frank J, Schoeniger D, Jekich BM, Barrientos RM, Maier SF, Watkins LR. Spinal gap junctions: potential involvement in pain facilitation. The Journal of Pain : Official Journal of the American Pain Society. 5: 392-405. PMID 15501197 DOI: 10.1016/J.Jpain.2004.06.006  0.812
2004 Twining CM, Sloane EM, Milligan ED, Chacur M, Martin D, Poole S, Marsh H, Maier SF, Watkins LR. Peri-sciatic proinflammatory cytokines, reactive oxygen species, and complement induce mirror-image neuropathic pain in rats. Pain. 110: 299-309. PMID 15275780 DOI: 10.1016/J.Pain.2004.04.008  0.734
2004 Milligan ED, Chavez RA, Langer SJ, Sloane EM, Chacur M, Wieseler-Frank JL, Frank MG, Flotte TR, Cruz P, Leinwand L, Shumilla JA, Forsayeth JR, Maier SF, Watkins LR. 530. Spinal interleukin-10 (IL-10) gene therapy using viral and non-viral vectors controls inflammatory- and chronic constriction injury-induced pain states in rats Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.477  0.823
2004 Milligan E, Langer S, Sloane E, Wieseler-Frank J, Frank M, Levkoff L, Mahoney J, Chavez R, Forsayeth J, Cruz P, Flotte T, Leinwand L, Maier S, Watkins L. Animal Models of Chronic Pain The Journal of Pain. 5: S16. DOI: 10.1016/J.Jpain.2004.02.029  0.775
2004 Sloane E, Langer S, Milligan E, Wieseler-Frank J, Mahoney J, Levkoff L, Cruz P, Flotte T, Leinwand L, Maier S, Watkins L. Animal Models of Chronic Pain The Journal of Pain. 5: S15. DOI: 10.1016/J.Jpain.2004.02.027  0.775
Show low-probability matches.